Thyroid Nodules in Men: Why the Cancer Math Is Different
Written by John P. Sabra, MD FACS
Updated September 2026
Educational only. This article is not medical advice. Always consult your physician about your individual situation.
Thyroid disease is usually framed as a women’s health issue, and the prevalence numbers explain why. Women have thyroid nodules three to four times more often than men. But the statistics on what those nodules turn out to be run differently in men, and that difference matters for your care.
Here is the part that gets missed: thyroid nodules are less common in men, but they are more likely to be cancer when they do occur. This is one of the most underappreciated facts in thyroid medicine, and it should shape how a nodule in a man is evaluated.
Thyroid nodules are found in roughly 50 to 60% of women over 50 on sensitive ultrasound, and in roughly 15 to 20% of men in the same age group. Of all thyroid nodules that get biopsied, about 5 to 10% are cancer overall. That average hides something important. In men, the cancer rate among biopsied nodules is closer to 10 to 15%, roughly double the rate in women. The same nodule, with the same TIRADS features, carries a higher probability of being malignant in a man than in a woman.
The biology behind this is not fully worked out. Sex hormones, immune system differences, and genetic factors all likely contribute. The clinical implication is straightforward: when evaluating a thyroid nodule in a man, the threshold for taking it seriously is lower than for a woman with an otherwise identical nodule.
What This Means for Evaluation
-
Standard TIRADS-based biopsy criteria still apply: The size thresholds are the same regardless of patient sex.
-
The pretest probability is different: A TR4 nodule in a man is more likely to be cancer than a TR4 nodule in a woman.
-
Bethesda III and IV (indeterminate) results carry slightly higher malignancy risk in men: Molecular testing and surgical decisions factor this in.
-
Cancers in men tend to present at slightly more advanced stage: Part of this is likely that thyroid disease sits lower on the differential for men, which can delay evaluation.
⚕ Clinical note A palpable neck mass or any neck symptom in a man warrants ultrasound evaluation, not reassurance based on the lower prevalence of thyroid disease. The lower prevalence is sometimes used as a reason to wait. The higher cancer rate per nodule means the opposite is true: when a nodule is present in a man, evaluation is at least as important as it would be in a woman.
Cancer Outcomes in Men
Thyroid cancer in men tends to behave somewhat differently than in women. The published data show that male sex is an independent risk factor for recurrence and for slightly worse long-term outcomes. The differences are modest, and overall survival for differentiated thyroid cancer in men remains very high, but the differences are real and worth naming.
| Feature | Women | Men |
|---|---|---|
| Prevalence of thyroid nodules | Higher (about 3 to 4 times more common) | Lower overall |
| Probability that a nodule is cancer | 5 to 8% on average | 10 to 15% on average |
| Stage at diagnosis | Often earlier | More often advanced |
| Recurrence risk | Lower | Slightly higher |
| Long-term survival | Excellent | Slightly lower but still excellent overall |
Practical Implications
-
A neck lump in a man warrants prompt evaluation: It should not be deferred or written off as a non-thyroid cause without testing.
-
Incidental thyroid findings in men should generally be pursued: A dedicated thyroid ultrasound is appropriate for incidental nodules of meaningful size in men.
-
The threshold for surgery in indeterminate biopsy results can sit slightly lower: A Bethesda IV in a man may favor surgery more strongly than the same result in a woman.
-
Active surveillance criteria are the same but applied with slightly more caution: Younger men with microcarcinoma are candidates for surveillance, but male sex is one factor among many in the decision.
⚕ Clinical note
None of these sex-based differences should change the core message that thyroid cancer outcomes are generally excellent. The differences are statistical. They matter for clinical decision-making, not for predicting how any one patient will do. A man newly diagnosed with thyroid cancer has the same access to excellent treatment and the same realistic expectation of long-term survival as a woman with the same diagnosis.
The Bottom Line
Thyroid nodules are less common in men but more likely to be cancer when they occur. The standard evaluation framework applies, but the threshold for taking a finding seriously should reflect the different statistical baseline. Male sex is one of several factors that shape how to manage a nodule or a cancer. Outcomes remain excellent for the great majority of men diagnosed with thyroid cancer.
If you are a man with a thyroid nodule or a new neck mass, make sure the workup proceeds with the standard radiology evaluation rather than being deferred on the assumption that thyroid disease is uncommon in men.
This article is intended for patient education only. It does not constitute medical advice and does not replace a consultation with your physician. Individual patient circumstances and clinical judgment determine the appropriate evaluation and management for every patient.
More from the Ultrasound series
Ready to Talk to a Specialist?
A thyroid specialist can review your specific results, answer your questions, and help you understand exactly what your next steps should be. The ATLAS network connects you with experienced thyroid and parathyroid expert physicians who focus on thyroid disease.
Find a Thyroid Specialist Near You →